PanGen Biotech Inc - Asset Resilience Ratio

Latest as of September 2025: 30.66%

PanGen Biotech Inc (222110) has an Asset Resilience Ratio of 30.66% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check PanGen Biotech Inc strategic asset allocation index to assess the company's strategic physical and investment asset allocation.

Liquid Assets

₩10.05 Billion

≈ $6.81 Million USD Cash + Short-term Investments

Total Assets

₩32.76 Billion

≈ $22.20 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2014–2024)

This chart shows how PanGen Biotech Inc's Asset Resilience Ratio has changed over time. See PanGen Biotech Inc balance sheet independence to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down PanGen Biotech Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see PanGen Biotech Inc stock valuation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩10.05 Billion	30.66%
Total Liquid Assets	₩10.05 Billion	30.66%

Asset Resilience Insights

Very High Liquidity: PanGen Biotech Inc maintains exceptional liquid asset reserves at 30.66% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

PanGen Biotech Inc Industry Peers by Asset Resilience Ratio

Compare PanGen Biotech Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Ascendis Pharma AS NASDAQ:ASND	Biotechnology	0.00%
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	0.00%
Spyre Therapeutics Inc. NASDAQ:SYRE	Biotechnology	84.34%
3SBio Inc F:83B	Biotechnology	10.64%
Soleno Therapeutics Inc NASDAQ:SLNO	Biotechnology	20.15%
Jiangxi Fushine Pharmaceutical Co Ltd SHE:300497	Biotechnology	0.02%
Novavax Inc NASDAQ:NVAX	Biotechnology	53.87%
BB Biotech AG SW:BION	Biotechnology	0.05%

Annual Asset Resilience Ratio for PanGen Biotech Inc (2014–2024)

The table below shows the annual Asset Resilience Ratio data for PanGen Biotech Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	37.42%	₩11.43 Billion ≈ $7.75 Million	₩30.54 Billion ≈ $20.70 Million	+37.20pp
2023-12-31	0.22%	₩45.06 Million ≈ $30.54K	₩20.74 Billion ≈ $14.06 Million	+0.21pp
2022-12-31	0.01%	₩2.00 Million ≈ $1.36K	₩20.67 Billion ≈ $14.01 Million	-55.22pp
2021-12-31	55.23%	₩23.90 Billion ≈ $16.20 Million	₩43.28 Billion ≈ $29.33 Million	+3.89pp
2020-12-31	51.33%	₩18.64 Billion ≈ $12.63 Million	₩36.31 Billion ≈ $24.61 Million	-11.00pp
2019-12-31	62.34%	₩24.36 Billion ≈ $16.51 Million	₩39.08 Billion ≈ $26.49 Million	-1.09pp
2018-12-31	63.42%	₩28.93 Billion ≈ $19.60 Million	₩45.61 Billion ≈ $30.91 Million	+13.46pp
2017-12-31	49.96%	₩17.78 Billion ≈ $12.05 Million	₩35.59 Billion ≈ $24.12 Million	+0.31pp
2016-12-31	49.65%	₩18.57 Billion ≈ $12.58 Million	₩37.40 Billion ≈ $25.34 Million	+43.72pp
2014-12-31	5.93%	₩1.00 Billion ≈ $677.69K	₩16.87 Billion ≈ $11.43 Million	--

pp = percentage points

About PanGen Biotech Inc

KQ:222110 Korea Biotechnology

Market Cap

$42.98 Million

₩63.42 Billion KRW

Market Cap Rank

#22524 Global

#1433 in Korea

Share Price

₩4700.00

Change (1 day)

-2.39%

52-Week Range

₩4510.00 - ₩7340.00

All Time High

₩24450.00